Cargando…

N-cadherin expression in malignant germ cell tumours of the testis

BACKGROUND: Testicular germ cell tumours (TGCTs) are the most common malignancy in young men aged 18–35 years. They are clinically and histologically subdivided into seminomas and non-seminomas. Cadherins are calcium-dependent transmembrane proteins of the group of adhesion proteins. They play a rol...

Descripción completa

Detalles Bibliográficos
Autores principales: Bremmer, Felix, Hemmerlein, Bernhard, Strauss, Arne, Burfeind, Peter, Thelen, Paul, Radzun, Heinz-Joachim, Behnes, Carl Ludwig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549730/
https://www.ncbi.nlm.nih.gov/pubmed/23066729
http://dx.doi.org/10.1186/1472-6890-12-19
_version_ 1782256456466169856
author Bremmer, Felix
Hemmerlein, Bernhard
Strauss, Arne
Burfeind, Peter
Thelen, Paul
Radzun, Heinz-Joachim
Behnes, Carl Ludwig
author_facet Bremmer, Felix
Hemmerlein, Bernhard
Strauss, Arne
Burfeind, Peter
Thelen, Paul
Radzun, Heinz-Joachim
Behnes, Carl Ludwig
author_sort Bremmer, Felix
collection PubMed
description BACKGROUND: Testicular germ cell tumours (TGCTs) are the most common malignancy in young men aged 18–35 years. They are clinically and histologically subdivided into seminomas and non-seminomas. Cadherins are calcium-dependent transmembrane proteins of the group of adhesion proteins. They play a role in the stabilization of cell-cell contacts, the embryonic morphogenesis, in the maintenance of cell polarity and signal transduction. N-cadherin (CDH2), the neuronal cadherin, stimulates cell-cell contacts during migration and invasion of cells and is able to suppress tumour cell growth. METHODS: Tumour tissues were acquired from 113 male patients and investigated by immunohistochemistry, as were the three TGCT cell lines NCCIT, NTERA-2 and Tcam2. A monoclonal antibody against N-cadherin was used. RESULTS: Tumour-free testis and intratubular germ cell neoplasias (unclassified) (IGCNU) strongly expressed N-cadherin within the cytoplasm. In all seminomas investigated, N-cadherin expression displayed a membrane-bound location. In addition, the teratomas and yolk sac tumours investigated also differentially expressed N-cadherin. In contrast, no N-cadherin could be detected in any of the embryonal carcinomas and chorionic carcinomas examined. This expression pattern was also seen in the investigated mixed tumours consisting of seminomas, teratomas, and embryonal carcinoma. CONCLUSIONS: N-cadherin expression can be used to differentiate embryonal carcinomas and chorionic carcinomas from other histological subtypes of TGCT.
format Online
Article
Text
id pubmed-3549730
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35497302013-01-23 N-cadherin expression in malignant germ cell tumours of the testis Bremmer, Felix Hemmerlein, Bernhard Strauss, Arne Burfeind, Peter Thelen, Paul Radzun, Heinz-Joachim Behnes, Carl Ludwig BMC Clin Pathol Research Article BACKGROUND: Testicular germ cell tumours (TGCTs) are the most common malignancy in young men aged 18–35 years. They are clinically and histologically subdivided into seminomas and non-seminomas. Cadherins are calcium-dependent transmembrane proteins of the group of adhesion proteins. They play a role in the stabilization of cell-cell contacts, the embryonic morphogenesis, in the maintenance of cell polarity and signal transduction. N-cadherin (CDH2), the neuronal cadherin, stimulates cell-cell contacts during migration and invasion of cells and is able to suppress tumour cell growth. METHODS: Tumour tissues were acquired from 113 male patients and investigated by immunohistochemistry, as were the three TGCT cell lines NCCIT, NTERA-2 and Tcam2. A monoclonal antibody against N-cadherin was used. RESULTS: Tumour-free testis and intratubular germ cell neoplasias (unclassified) (IGCNU) strongly expressed N-cadherin within the cytoplasm. In all seminomas investigated, N-cadherin expression displayed a membrane-bound location. In addition, the teratomas and yolk sac tumours investigated also differentially expressed N-cadherin. In contrast, no N-cadherin could be detected in any of the embryonal carcinomas and chorionic carcinomas examined. This expression pattern was also seen in the investigated mixed tumours consisting of seminomas, teratomas, and embryonal carcinoma. CONCLUSIONS: N-cadherin expression can be used to differentiate embryonal carcinomas and chorionic carcinomas from other histological subtypes of TGCT. BioMed Central 2012-10-15 /pmc/articles/PMC3549730/ /pubmed/23066729 http://dx.doi.org/10.1186/1472-6890-12-19 Text en Copyright ©2012 Bremmer et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bremmer, Felix
Hemmerlein, Bernhard
Strauss, Arne
Burfeind, Peter
Thelen, Paul
Radzun, Heinz-Joachim
Behnes, Carl Ludwig
N-cadherin expression in malignant germ cell tumours of the testis
title N-cadherin expression in malignant germ cell tumours of the testis
title_full N-cadherin expression in malignant germ cell tumours of the testis
title_fullStr N-cadherin expression in malignant germ cell tumours of the testis
title_full_unstemmed N-cadherin expression in malignant germ cell tumours of the testis
title_short N-cadherin expression in malignant germ cell tumours of the testis
title_sort n-cadherin expression in malignant germ cell tumours of the testis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549730/
https://www.ncbi.nlm.nih.gov/pubmed/23066729
http://dx.doi.org/10.1186/1472-6890-12-19
work_keys_str_mv AT bremmerfelix ncadherinexpressioninmalignantgermcelltumoursofthetestis
AT hemmerleinbernhard ncadherinexpressioninmalignantgermcelltumoursofthetestis
AT straussarne ncadherinexpressioninmalignantgermcelltumoursofthetestis
AT burfeindpeter ncadherinexpressioninmalignantgermcelltumoursofthetestis
AT thelenpaul ncadherinexpressioninmalignantgermcelltumoursofthetestis
AT radzunheinzjoachim ncadherinexpressioninmalignantgermcelltumoursofthetestis
AT behnescarlludwig ncadherinexpressioninmalignantgermcelltumoursofthetestis